Pathophysiology of overactive bladder
- PMID: 22310925
- DOI: 10.1007/s00192-012-1682-6
Pathophysiology of overactive bladder
Abstract
Overactive bladder (OAB) is a common disorder that negatively affects the quality of life of our patients and carries a large socioeconomic burden. According to the International Continence Society, it is characterized as urinary urgency, with or without urge incontinence, usually, with frequency and nocturia in the absence of causative infection. The pathophysiology of this disease entity varies between neurogenic, myogenic, or idiopathic factors. This paper provides a review of the contemporary theories behind the pathophysiology of OAB.
Similar articles
-
[Terminology and Pathophysiology of Overactive Bladder (OAB)].Aktuelle Urol. 2016 Dec;47(6):468-474. doi: 10.1055/s-0042-108871. Epub 2016 Sep 6. Aktuelle Urol. 2016. PMID: 27598780 Review. German.
-
OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.Eur Urol. 2013 Aug;64(2):249-56. doi: 10.1016/j.eururo.2013.04.001. Epub 2013 Apr 10. Eur Urol. 2013. PMID: 23608668 Clinical Trial.
-
A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment.Eur Urol. 2019 Jun;75(6):988-1000. doi: 10.1016/j.eururo.2019.02.038. Epub 2019 Mar 26. Eur Urol. 2019. PMID: 30922690 Review.
-
Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladder.Expert Opin Pharmacother. 2011 May;12(7):1017-27. doi: 10.1517/14656566.2011.554396. Epub 2011 Feb 26. Expert Opin Pharmacother. 2011. PMID: 21473706 Review.
-
Chapter 1: The conditions of neurogenic detrusor overactivity and overactive bladder.Neurourol Urodyn. 2014 Jul;33 Suppl 3:S2-5. doi: 10.1002/nau.22636. Neurourol Urodyn. 2014. PMID: 25042138 Review.
Cited by
-
Impact of smoking habit on overactive bladder symptoms and incontinence in women.Int J Urol. 2020 Dec;27(12):1078-1086. doi: 10.1111/iju.14357. Epub 2020 Sep 1. Int J Urol. 2020. PMID: 32875688 Free PMC article.
-
Cost-Utility Analysis of Oxybutynin vs. OnabotulinumtoxinA (Botox) in the Treatment of Overactive Bladder Syndrome.Int J Environ Res Public Health. 2021 Aug 19;18(16):8743. doi: 10.3390/ijerph18168743. Int J Environ Res Public Health. 2021. PMID: 34444493 Free PMC article.
-
Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action.Toxins (Basel). 2016 Apr 21;8(4):120. doi: 10.3390/toxins8040120. Toxins (Basel). 2016. PMID: 27110822 Free PMC article. Review.
-
Pre- versus Post-Menopausal Onset of Overactive Bladder and the Response to Vaginal Estrogen Therapy: A Prospective Study.Medicina (Kaunas). 2023 Jan 27;59(2):245. doi: 10.3390/medicina59020245. Medicina (Kaunas). 2023. PMID: 36837446 Free PMC article.
-
Validation of the urgency questionnaire in Portuguese: A new instrument to assess overactive bladder syndrome.Int Braz J Urol. 2018 Mar-Apr;44(2):338-347. doi: 10.1590/S1677-5538.IBJU.2017.0147. Int Braz J Urol. 2018. PMID: 29219282 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
